IPSC (Century Therapeutics Inc) climbed 8.18 at the last close: Is This Today’s Most Popular Stock?

Zack King

Century Therapeutics Inc (NASDAQ: IPSC) on Monday, soared 8.18% from the previous trading day, before settling in for the closing price of $0.51. Within the past 52 weeks, IPSC’s price has moved between $0.34 and $1.83.

Healthcare Sector giant saw their annual sales surged by 18.46% over the last five years. The company achieved an average annual earnings per share of 93.01%. With a float of $40.13 million, this company’s outstanding shares have now reached $86.32 million.

The firm has a total of 150 workers. Let’s measure their productivity.

Century Therapeutics Inc (IPSC) Breakdown of a Key Holders of the stock

Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Century Therapeutics Inc is 53.54%, while institutional ownership is 23.59%. The most recent insider transaction that took place on Sep 08 ’25, was worth 132. In this transaction SVP Finance & Operations of this company sold 263 shares at a rate of $0.50, taking the stock ownership to the 405,423 shares. Before that another transaction happened on Sep 08 ’25, when Company’s President and CEO sold 488 for $0.50, making the entire transaction worth $244. This insider now owns 3,268,909 shares in total.

Century Therapeutics Inc (IPSC) Recent Fiscal highlights

As on 9/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.37 earnings per share (EPS) for the period topping the consensus outlook (set at -0.45) by 0.08. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.32 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 93.01% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 10.74% during the next five years compared to 18.46% growth over the previous five years of trading.

Century Therapeutics Inc (NASDAQ: IPSC) Trading Performance Indicators

Century Therapeutics Inc (IPSC) is currently performing well based on its current performance indicators. A quick ratio of 10.72 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.42.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.28, a number that is poised to hit -0.34 in the next quarter and is forecasted to reach -1.24 in one year’s time.

Technical Analysis of Century Therapeutics Inc (IPSC)

Analysing the last 5-days average volume posted by the [Century Therapeutics Inc, IPSC], we can find that recorded value of 0.74 million was better than the volume posted last year of 0.7 million. As of the previous 9 days, the stock’s Stochastic %D was 74.43%.

During the past 100 days, Century Therapeutics Inc’s (IPSC) raw stochastic average was set at 41.90%, which indicates a significant decrease from 76.32% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0253 in the past 14 days, which was lower than the 0.0369 volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $0.5189, while its 200-day Moving Average is $0.6272. Now, the first resistance to watch is $0.5885. This is followed by the second major resistance level at $0.6216. The third major resistance level sits at $0.6634. If the price goes on to break the first support level at $0.5136, it is likely to go to the next support level at $0.4718. Now, if the price goes above the second support level, the third support stands at $0.4387.

Century Therapeutics Inc (NASDAQ: IPSC) Key Stats

Market capitalization of the company is 47.97 million based on 86,389K outstanding shares. Right now, sales total 6,590 K and income totals -126,570 K. The company made 109,160 K in profit during its latest quarter, and 76,560 K in sales during its previous quarter.

News Daemon
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.